IDO2 and adenocarcinoma: In the adenocarcinomas group, the univariate analysis showed that the patients with higher levels of PD-L2 (p = 0.02), IDO-2 (p = 0.005) and INFγ (p = 0.01) had a shorter RFS than patients with lower levels.